EP0877030A3 - EPO primary response gene 1,(EPRG1) - Google Patents

EPO primary response gene 1,(EPRG1) Download PDF

Info

Publication number
EP0877030A3
EP0877030A3 EP98303597A EP98303597A EP0877030A3 EP 0877030 A3 EP0877030 A3 EP 0877030A3 EP 98303597 A EP98303597 A EP 98303597A EP 98303597 A EP98303597 A EP 98303597A EP 0877030 A3 EP0877030 A3 EP 0877030A3
Authority
EP
European Patent Office
Prior art keywords
eprg1
primary response
response gene
epo
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98303597A
Other languages
German (de)
French (fr)
Other versions
EP0877030A2 (en
Inventor
Kenneth SmithKline Beecham Plarm. Lord
Susan SmithKline Beecham Plarm. Dillon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0877030A2 publication Critical patent/EP0877030A2/en
Publication of EP0877030A3 publication Critical patent/EP0877030A3/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Abstract

EPRG1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing EPRGI polypeptides and polynucleotides in therapy, and diagnostic assays for such.
EP98303597A 1997-05-07 1998-05-07 EPO primary response gene 1,(EPRG1) Withdrawn EP0877030A3 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
1996-12-30
US4589097P 1997-05-07 1997-05-07
US45890P 1997-05-07
US7134298A 1998-05-01 1998-05-01
US71342 1998-05-01
CA002230986A CA2230986A1 (en) 1997-05-07 1998-05-07 Epo primary response gene 1, eprg1

Publications (2)

Publication Number Publication Date
EP0877030A2 EP0877030A2 (en) 1998-11-11
EP0877030A3 true EP0877030A3 (en) 2001-05-23

Family

ID=27170641

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98303597A Withdrawn EP0877030A3 (en) 1997-05-07 1998-05-07 EPO primary response gene 1,(EPRG1)

Country Status (3)

Country Link
EP (1) EP0877030A3 (en)
JP (1) JPH11103867A (en)
CA (1) CA2230986A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2276685A1 (en) * 1997-11-03 1999-05-14 Incyte Pharmaceuticals, Inc. Suppressor of cytokine signaling
WO2001029178A2 (en) * 1999-10-21 2001-04-26 Smithkline Beecham Corporation Epo primary response gene 1, eprg1
WO2002101047A1 (en) * 2001-06-12 2002-12-19 Smithkline Beecham Corporation Method of identifying compounds that modulate epo primary response gene 1, eprg1, activities

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020023A1 (en) * 1996-11-01 1998-05-14 The Walter And Eliza Hall Institute Of Medical Research Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
WO1998039448A2 (en) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
WO1999003993A2 (en) * 1997-07-18 1999-01-28 Schering Corporation Suppressors of cytokine signaling; related reagents
WO1999023220A1 (en) * 1997-11-03 1999-05-14 Incyte Pharmaceuticals, Inc. Suppressor of cytokine signaling

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020023A1 (en) * 1996-11-01 1998-05-14 The Walter And Eliza Hall Institute Of Medical Research Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
WO1998039448A2 (en) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
WO1999003993A2 (en) * 1997-07-18 1999-01-28 Schering Corporation Suppressors of cytokine signaling; related reagents
WO1999023220A1 (en) * 1997-11-03 1999-05-14 Incyte Pharmaceuticals, Inc. Suppressor of cytokine signaling

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HILLIER L. ET AL.: "WashU-Merck EST Project 1997; zt52e09.r1 Soares ovary tumor NbHOT Homo sapiens cDNA clone IMAGE:725992 5' similar to contains element PTR5 repetitive element; mRNA sequence", EMBL DATABASE ENTRY HS1199841; ACCESSION NO. AA399299, 29 April 1997 (1997-04-29), XP002163363 *
MASUHARA M. ET AL.: "Cloning and characterization of novel CIS family genes", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 239, 1 October 1997 (1997-10-01), pages 439 - 446, XP002088457, ISSN: 0006-291X *
MINAMOTO S. ET AL.: "Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI.2 and SSI-3", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 237, no. 1, 8 August 1997 (1997-08-08), pages 79 - 83, XP002095406, ISSN: 0006-291X *
STARR R. ET AL.: "A family of cytokine-inducible inhibitors of signalling", NATURE, vol. 387, 26 June 1997 (1997-06-26), pages 917 - 921, XP002085491, ISSN: 0028-0836 *

Also Published As

Publication number Publication date
CA2230986A1 (en) 1998-11-07
EP0877030A2 (en) 1998-11-11
JPH11103867A (en) 1999-04-20

Similar Documents

Publication Publication Date Title
EP1001023A3 (en) Frizzled-4, a putative Wnt-receptor
WO1998031799A3 (en) Polynucleotides and polypeptides encoding receptors
EP0939124A3 (en) MGBP1 sequences
WO1998057983A3 (en) Mammalian neuro-growth factor like protein
WO2001066690A3 (en) Novel compounds
EP0911399A3 (en) A kringle-related clone, HTHBZ47
WO2001072961A3 (en) Novel compounds
WO1999035266A3 (en) Human urotensin ii
EP0879888A3 (en) Patched-2 polypeptides and polynucleotides and methods for their production
EP0943684A3 (en) Frizzled-like polypeptides and polynucleotides
EP0885959A3 (en) Human Wnt-5b protein
EP0877030A3 (en) EPO primary response gene 1,(EPRG1)
WO2001029178A3 (en) Epo primary response gene 1, eprg1
EP0879879A3 (en) Polypeptide deformylase 1 (Def1)
WO2001004141A3 (en) Seripancrin
EP0887416A3 (en) Human AFC1
EP0911391A3 (en) A clone HWHHJ20
WO2001032864A3 (en) Gpcr-kd5 polypeptides and dna sequences thereof
EP0887415A3 (en) Human RCE1
EP0890646A3 (en) HE2NW40 Serine Protease
WO1999011783A3 (en) T-box polypeptides
CA2187386A1 (en) Gene encoding endo-.beta.-n-acetylglucosaminidase a
EP0882791A3 (en) WNT-11 polypeptides
EP0875570A3 (en) Neurodegenerative polypeptides HHPDZ65
WO2002004600A3 (en) Novel compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): BE CH DE DK FR GB IT LI NL

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17P Request for examination filed

Effective date: 20011123

AKX Designation fees paid

Free format text: BE CH DE DK FR GB IT LI NL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 20020923